ArticleJournal of cancer research and clinical oncology2020

New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified.

Ian A MacNeil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.